BAJAJ BROKING

Notification close image
No new Notification messages
card image
Accretion Pharmaceuticals IPO is Open!
Apply for the Accretion Pharmaceuticals IPO through UPI in just minutes.
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

IREDA Files Insolvency Plea Against Gensol Over ₹510 Crore Default

Synopsis:

IREDA has moved the NCLT against Gensol Engineering Ltd over a ₹510 crore default. Gensol Engineering share price has crashed 94% in 2025 amid SEBI bans and top-level exits. The application was filed under Section 7 of the IBC.


State-owned financier Indian Renewable Energy Development Agency Ltd (IREDA) has filed an insolvency application against Gensol Engineering Ltd for defaulting on dues worth ₹510 crore. The move, initiated under Section 7 of the Insolvency and Bankruptcy Code, marks a significant escalation in the financial troubles of the crisis-hit renewable energy player. The case has been submitted to the National Company Law Tribunal (NCLT) for the initiation of the Corporate Insolvency Resolution Process (CIRP).

Also read: Brigade Enterprises Acquires Chennai Land Parcel Worth ₹441.7 Crore

INDIAN RENEWABLE ENERGY

Trade

166.75-1.03 (-0.61 %)

Updated - 15 May 2025
169.25day high
DAY HIGH
165.31day low
DAY LOW
12210205
VOLUME (BSE)

Key Takeaways:

  1. IREDA filed an insolvency application citing ₹510 crore default.

  2. The application falls under Section 7 of the Insolvency and Bankruptcy Code.

  3. Gensol shares have hit the lower circuit 18 sessions in a row.

  4. Top leadership at Gensol has resigned citing regulatory pressure.

  5. SEBI has barred the Jaggi brothers from capital markets.

Also read: Infosys Sells HIPUS Stake to Mitsubishi Heavy, Strengthens Japan Ties

Collapse In Share Value And Leadership Crisis

Gensol Engineering share price has plummeted by over 94% since January 2025, falling from a high of ₹1,124 to ₹51.25. This freefall began following allegations of governance failures and was exacerbated by regulatory intervention. The Securities and Exchange Board of India (SEBI) had earlier restricted Anmol Singh Jaggi and Puneet Singh Jaggi—both key directors—from accessing the capital markets. Their resignation this week has further dented investor confidence.

Gensol Share Performance Snapshot

Date

Gensol Engineering Share Price

Change (%)

01 January 2025

₹1,124

13 May 2025

₹51.25

-94% YTD

Last 23 Sessions

Lower Circuit Hit

18 Times

IREDA’s Legal Move And Market Impact

The filing under Section 7 of the IBC enables financial creditors like IREDA to push for insolvency proceedings once a default is verified. This could lead to a restructuring or liquidation process under NCLT supervision. IREDA share price remained largely unaffected in early trades, reflecting investor confidence in its portfolio diversity.

With IREDA initiating insolvency proceedings, Gensol Engineering faces its most serious challenge yet. The ongoing fall in Gensol Engineering share price and mounting regulatory pressure have cast uncertainty over the company's future, while IREDA remains proactive in safeguarding its financial interests.

Also read: SBI to Evaluate USD 3 Billion Fundraising Plan on May 20 for FY26

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|